Table 1.
Parameter | AL (n = 16) | Without AL (n = 254) | P value |
---|---|---|---|
Gender, M (%) | 12 (75.0) | 150 (59.1) | 0.294 |
Age, mean ± s (years) | 61.3 ± 10.3 | 62.7 ± 7.1 | 0.608 |
Comorbidities, n (%) | |||
Metabolic | 3 (18.8) | 13 (5.1) | 0.060 |
Cardiovascular | 6 (37.5) | 52 (20.5) | 0.120 |
ASA score, n (%) | 0.544 | ||
1-2 | 12 (75.0) | 172 (67.7) | |
3 | 4 (25.0) | 82 (32.3) | |
Neo-adjuvant CRT, n (%) | 5 (31.3) | 26 (10.2) | 0.010 |
Stage, TNM, n (%) | 0.070 | ||
I | 1 (6.2) | 76 (29.9) | |
II | 7 (43.8) | 54 (21.3) | |
III | 8 (50.0) | 114 (44.9) | |
IV | 0 (0) | 10 (3.9) |